UPDATE: Citi Upgrades Vanda Pharmaceuticals (VNDA) to Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. USO
5. TSLA
6. GNK
7. FNGR
8. PLUR
9. MU
10. ARGX

Go back to UPDATE: Citi Upgrades Vanda Pharmaceuticals (VNDA) to Buy

Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 2c, Revenues Miss; Offers FY20 Revenue Outlook

October 28, 2020 4:04 PM EDT

Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of $0.11, $0.02 better than the analyst estimate of $0.09. Revenue for the quarter came in at $60.31 million versus the consensus estimate of $63.95 million.

Key Financial and Corporate Highlights

Third Quarter of 2020

Total net product sales from HETLIOZ® and... More